Breast cancer subtype dictates DNA methylation and ALDH1A3-mediated expression of tumor suppressor RARRES1

Breast cancer subtyping, based on the expression of hormone receptors and other genes, can determine patient prognosis and potential options for targeted therapy. Among breast cancer subtypes, tumors of basal-like and claudin-low subtypes are typically associated with worse patient outcomes, are pri...

Descripción completa

Detalles Bibliográficos
Autores principales: Coyle, Krysta M., Murphy, J. Patrick, Vidovic, Dejan, Vaghar-Kashani, Ahmad, Dean, Cheryl A., Sultan, Mohammad, Clements, Derek, Wallace, Melissa, Thomas, Margaret L., Hundert, Amos, Giacomantonio, Carman A., Helyer, Lucy, Gujar, Shashi A., Lee, Patrick W.K., Weaver, Ian C.G., Marcato, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5190082/
https://www.ncbi.nlm.nih.gov/pubmed/27286452
http://dx.doi.org/10.18632/oncotarget.9858

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5190082/
https://www.ncbi.nlm.nih.gov/pubmed/27286452
http://dx.doi.org/10.18632/oncotarget.9858

Ejemplares similares